Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 908098, 14 pages
http://dx.doi.org/10.1155/2014/908098
Research Article

Impact of Ellagic Acid in Bone Formation after Tooth Extraction: An Experimental Study on Diabetic Rats

1Centre of Studies for Periodontology, Faculty of Dentistry, Universiti Teknologi MARA, 40450 Shah Alam, Malaysia
2Faculty of Medicine, Universiti Teknologi MARA, Jalan Hospital, Sungai Buloh Campus, 47000 Sungai Buloh, Selangor, Malaysia
3DDH CoRe, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
4Center of Preclinical Science, Faculty of Dentistry, Universiti Teknologi MARA, 40450 Shah Alam, Selangor Darul Ehsan, Malaysia

Received 17 May 2014; Revised 5 August 2014; Accepted 26 August 2014; Published 18 November 2014

Academic Editor: Niroshani Soysa

Copyright © 2014 Mazen M. Jamil Al-Obaidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. S. O'Ryan and J. C. Lo, “Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes,” Journal of Oral and Maxillofacial Surgery, vol. 70, no. 8, pp. 1844–1853, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. Araújo and J. Lindhe, “Ridge alterations following tooth extraction with and without flap elevation: an experimental study in the dog,” Clinical Oral Implants Research, vol. 20, no. 6, pp. 545–549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. L. Mealey and G. L. Ocampo, “Diabetes mellitus and periodontal disease,” Periodontology 2000, vol. 44, no. 1, pp. 127–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. T. Vernillo, “Diabetes mellitus: relevance to dental treatment,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 91, no. 3, pp. 263–270, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mellado-Valero, J. C. Ferrer García, A. Herrera Ballester, and C. Labaig Rueda, “Effects of diabetes on the osseointegration of dental implants,” Medicina Oral, Patología Oral y Cirugía Bucal, vol. 12, no. 1, pp. E38–E43, 2007. View at Google Scholar · View at Scopus
  6. G. W. Bell, D. M. Large, and S. C. Barclay, “Oral health care in diabetes mellitus,” Dental Update, vol. 26, no. 8, pp. 322–330, 1999. View at Google Scholar · View at Scopus
  7. R. Zhang, Z. G. Liu, C. Li et al., “Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats,” Bone, vol. 45, no. 3, pp. 553–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Pari and R. Sivasankari, “Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats,” Fundamental & Clinical Pharmacology, vol. 22, no. 4, pp. 395–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. O. Çeribaşi, G. Türk, M. Sönmez, F. Sakin, and A. Ateahin, “Toxic effect of cyclophosphamide on sperm morphology, testicular histology and blood oxidant—antioxidant balance, and protective roles of lycopene and ellagic acid,” Basic & Clinical Pharmacology & Toxicology, vol. 107, no. 3, pp. 730–736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Türk, A. Ateşşahin, M. Sönmez, A. O. Çeribaşi, and A. Yüce, “Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid,” Fertility and Sterility, vol. 89, no. 5, pp. 1474–1481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Türk, A. O. Çeribaşi, F. Sakin, M. Sönmez, and A. Ateşşahin, “Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis,” Reproduction, Fertility and Development, vol. 22, no. 4, pp. 587–596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. I. Priyadarsini, S. M. Khopde, S. S. Kumar, and H. Mohan, “Free radical studies of ellagic acid, a natural phenolic antioxidant,” Journal of Agricultural and Food Chemistry, vol. 50, no. 7, pp. 2200–2206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. K. C. Thresiamma and R. Kuttan, “Inhibition of liver fibrosis by ellagic acid,” Indian Journal of Physiology and Pharmacology, vol. 40, no. 4, pp. 363–366, 1996. View at Google Scholar · View at Scopus
  14. T. Iino, K. Tashima, M. Umeda et al., “Effect of ellagic acid on gastric damage induced in ischemic rat stomachs following ammonia or reperfusion,” Life Sciences, vol. 70, no. 10, pp. 1139–1150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Aviram, M. Rosenblat, D. Gaitini et al., “Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation,” Clinical Nutrition, vol. 23, no. 3, pp. 423–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Akiyama, K. Fujii, O. Yamasaki, T. Oono, and K. Iwatsuki, “Antibacterial action of several tannins against Staphylococcus aureus,” Journal of Antimicrobial Chemotherapy, vol. 48, no. 4, pp. 487–491, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Martino, J. Morales, J. J. Martínez-Irujo, M. Font, A. Monge, and J. Coussio, “Two ellagitannins from the leaves of Terminalia triflora with inhibitory activity on HIV-1 reverse transcriptase,” Phytotherapy Research, vol. 18, no. 8, pp. 667–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. J. Al-Obaidi, F. H. Al-Bayaty, R. Al Batran, P. Hassandarvish, and E. Rouhollahi, “Protective effect of ellagic acid on healing alveolar bone after tooth extraction in rat—a histological and immunohistochemical study,” Archives of Oral Biology, vol. 59, no. 9, pp. 987–999, 2014. View at Google Scholar
  19. I. R. Garrett, G. Gutierrez, and G. R. Mundy, “Statins and bone formation,” Current Pharmaceutical Design, vol. 7, no. 8, pp. 715–736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Mundy, R. Garrett, S. Harris et al., “Stimulation of bone formation in vitro and in rodents by statins,” Science, vol. 286, no. 5446, pp. 1946–1949, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Ohnaka, S. Shimoda, H. Nawata et al., “Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of rho-associated kinase in human osteoblasts,” Biochemical and Biophysical Research Communications, vol. 287, no. 2, pp. 337–342, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. G. N. King and F. J. Hughes, “Bone morphogenetic protein-2 stimulates cell recruitment and cementogenesis during early wound healing,” Journal of Clinical Periodontology, vol. 28, no. 5, pp. 465–475, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Pitaru, A. Pritzki, I. Bar-Kana, A. Grosskopf, N. Savion, and A. S. Narayanan, “Bone morphogenetic protein 2 induces the expression of cementum attachment protein in human periodontal ligament clones,” Connective Tissue Research, vol. 43, no. 2-3, pp. 257–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. K. A. Selvig, R. G. Sorensen, J. M. Wozney, and U. M. E. Wikesjö, “Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration,” Journal of Periodontology, vol. 73, no. 9, pp. 1020–1029, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Ayukawa, E. Yasukawa, Y. Moriyama et al., “Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 3, pp. 336–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. W. A. Grasser, A. P. Baumann, S. F. Petras et al., “Regulation of osteoclast differentiation by statins,” Journal of Musculoskeletal Neuronal Interactions, vol. 3, no. 1, pp. 53–62, 2003. View at Google Scholar · View at Scopus
  27. M. J. Seibel, “Biochemical markers of bone turnover part I: biochemistry and variability,” The Clinical Biochemist Reviews, vol. 26, no. 4, pp. 97–122, 2005. View at Google Scholar
  28. S. Hankemeier, M. Keus, J. Zeichen et al., “Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments,” Tissue Engineering, vol. 11, no. 1-2, pp. 41–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Moya, M. H. Cheng, J. J. Huang et al., “The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering,” Biomaterials, vol. 31, no. 10, pp. 2816–2826, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Arya, M. M. Jamil, N. Shahid et al., “Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: a mechanistic study,” Food and Chemical Toxicology, vol. 71, pp. 183–196, 2014. View at Publisher · View at Google Scholar
  31. S. K. Mitra, S. Gopumadhavan, T. S. Muralidhar, S. D. Anturlikar, and M. B. Sujatha, “Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats,” Journal of Ethnopharmacology, vol. 54, no. 1, pp. 41–46, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Okamoto and M. de Campos Russo, “Wound healing following tooth extraction. Histochemical study in rats,” Revista da Faculdade de Odontologia de Aracatuba, vol. 2, no. 2, pp. 153–169, 1973. View at Google Scholar · View at Scopus
  33. S. T. Sonis, B. A. Watkins, G. D. Lyng, M. A. Lerman, and K. C. Anderson, “Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients,” Oral Oncology, vol. 45, no. 2, pp. 164–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. E. S. Elsubeihi and J. N. Heersche, “Quantitative assessment of post-extraction healing and alveolar ridge remodelling of the mandible in female rats,” Archives of Oral Biology, vol. 49, no. 5, pp. 401–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Morrisey and J. Carpenter, “Formulary,” in Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery, pp. 436–444, 2nd edition, 2004. View at Google Scholar
  36. M. M. J. Al-Obaidi, F. H. Al-Bayaty, R. Al-Batran et al., “Evaluation of the potential effect of ellagic acid on cotinine and antioxidant levels in nicotine-induced rats,” International Medical Journal, vol. 21, no. 2, pp. 150–155, 2014. View at Google Scholar
  37. N. Manrique, C. C. S. Pereira, L. M. G. Garcia et al., “Alveolar bone healing process in spontaneously hypertensive rats (SHR). A radiographic densitometry study,” Journal of Applied Oral Science, vol. 20, no. 2, pp. 222–227, 2012. View at Google Scholar · View at Scopus
  38. W.-L. Lin, C. A. McCulloch, and M.-I. Cho, “Differentiation of periodontal ligament fibroblasts into osteoblasts during socket healing after tooth extraction in the rat,” The Anatomical Record, vol. 240, no. 4, pp. 492–506, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Alp, I. Aytekin, O. Atakisi et al., “The effects of caffeic acid phenethyl ester and ellagic acid on the levels of malondialdehyde, reduced glutathione and nitric oxide in the lung, liver and kidney tissues in acute diazinon toxicity in rats,” Journal of Animal and Veterinary Advances, vol. 10, no. 11, pp. 1488–1494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Beauchamp and I. Fridovich, “Superoxide dismutase: improved assays and an assay applicable to acrylamide gels,” Analytical Biochemistry, vol. 44, no. 1, pp. 276–287, 1971. View at Google Scholar · View at Scopus
  42. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  43. J. G. Bijron, G. Ning, A. R. Laury et al., “Digital quantification of precursor frequency in the fallopian tube and its significance,” Modern Pathology, vol. 25, no. 12, pp. 1654–1661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Hla, M.-J. Lee, N. Ancellin, J. H. Paik, and M. J. Kluk, “Lysophospholipids—receptor revelations,” Science, vol. 294, no. 5548, pp. 1875–1878, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. J. S. Pober and W. C. Sessa, “Evolving functions of endothelial cells in inflammation,” Nature Reviews Immunology, vol. 7, no. 10, pp. 803–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. S. Nanes, “Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology,” Gene, vol. 321, no. 1-2, pp. 1–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Ahad, A. A. Ganai, M. Mujeeb, and W. A. Siddiqui, “Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy,” Chemico-Biological Interactions, vol. 219C, pp. 64–75, 2014. View at Publisher · View at Google Scholar
  48. L. Gilbert, X. He, P. Farmer et al., “Inhibition of osteoblast differentiation by tumor necrosis factor-α,” Endocrinology, vol. 141, no. 11, pp. 3956–3964, 2000. View at Google Scholar · View at Scopus
  49. L. C. Gilbert, J. Rubin, and M. S. Nanes, “The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 5, pp. E1011–E1018, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. F. H. Zhou, B. K. Foster, X.-F. Zhou, A. J. Cowin, and C. J. Xian, “TNF-α mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats,” Journal of Bone and Mineral Research, vol. 21, no. 7, pp. 1075–1088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Mukai, F. Otsuka, H. Otani et al., “TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling,” Biochemical and Biophysical Research Communications, vol. 356, no. 4, pp. 1004–1010, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. R. A. Eliseev, E. M. Schwarz, M. J. Zuscik, R. J. O'Keefe, H. Drissi, and R. N. Rosier, “Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB,” Experimental Cell Research, vol. 312, no. 1, pp. 40–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Guo, M. Yamashita, Q. Zhang et al., “Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins,” The Journal of Biological Chemistry, vol. 283, no. 34, pp. 23084–23092, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Lechleitner, T. Koch, M. Herold, A. Dzien, and F. Hoppichler, “Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors,” Journal of Internal Medicine, vol. 248, no. 1, pp. 67–76, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Tomomatsu, K. Aoki, N. Alles et al., “LPS-induced inhibition of osteogenesis is TNF-α dependent in a murine tooth extraction model,” Journal of Bone and Mineral Research, vol. 24, no. 10, pp. 1770–1781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. M. Janssen-Heininger, M. E. Poynter, and P. A. Baeuerle, “Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB,” Free Radical Biology & Medicine, vol. 28, no. 9, pp. 1317–1327, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Y. Schubert, I. Neeman, and N. Resnick, “A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants,” The FASEB Journal, vol. 16, no. 14, pp. 1931–1933, 2002. View at Google Scholar · View at Scopus
  58. S. Pavlica and R. Gebhardt, “Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells,” Free Radical Research, vol. 39, no. 12, pp. 1377–1390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Masamune, M. Satoh, K. Kikuta, N. Suzuki, K. Satoh, and T. Shimosegawa, “Ellagic acid blocks activation of pancreatic stellate cells,” Biochemical Pharmacology, vol. 70, no. 6, pp. 869–878, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Umesalma and G. Sudhandiran, “Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-κB, iNOS, COX-2, TNF-α, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis,” Basic & Clinical Pharmacology & Toxicology, vol. 107, no. 2, pp. 650–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. C.-Y. Chao, M.-C. Mong, K.-C. Chan, and M.-C. Yin, “Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice,” Molecular Nutrition and Food Research, vol. 54, no. 3, pp. 388–395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. B. M. Babior, “The respiratory burst of phagocytes,” Journal of Clinical Investigation, vol. 73, no. 3, pp. 599–601, 1984. View at Publisher · View at Google Scholar · View at Scopus
  63. Y.-Y. Soong and P. J. Barlow, “Quantification of gallic acid and ellagic acid from longan (Dimocarpus longan Lour.) seed and mango (Mangifera indica L.) kernel and their effects on antioxidant activity,” Food Chemistry, vol. 97, no. 3, pp. 524–530, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. E. A. Hassoun, J. Vodhanel, and A. Abushaban, “The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure,” Journal of Biochemical and Molecular Toxicology, vol. 18, no. 4, pp. 196–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. N. P. Seeram, L. S. Adams, S. M. Henning et al., “In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice,” Journal of Nutritional Biochemistry, vol. 16, no. 6, pp. 360–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. N. Laranjinha, L. M. Almeida, and V. M. C. Madeira, “Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation,” Biochemical Pharmacology, vol. 48, no. 3, pp. 487–494, 1994. View at Google Scholar · View at Scopus
  67. T. Iino, K. Nakahara, W. Miki et al., “Less damaging effect of whisky in rat stomachs in comparison with pure ethanol,” Digestion, vol. 64, no. 4, pp. 214–221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Uzar, H. Alp, M. U. Cevik et al., “Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats,” Neurological Sciences, vol. 33, no. 3, pp. 567–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Luqman and S. I. Rizvi, “Protection of lipid peroxidation and carbonyl formation in proteins by capsaicin in human erythrocytes subjected to oxidative stress,” Phytotherapy Research, vol. 20, no. 4, pp. 303–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, vol. 3, Oxford University Press, Oxford, UK, 1999.
  71. J. M. McCord, “Human disease, free radicals, and the oxidant/antioxidant balance,” Clinical Biochemistry, vol. 26, no. 5, pp. 351–357, 1993. View at Publisher · View at Google Scholar · View at Scopus
  72. A. M. S. E. S. Beserra, P. I. Calegari, M. D. C. Souza et al., “Gastroprotective and ulcer-healing mechanisms of ellagic acid in experimental rats,” Journal of Agricultural and Food Chemistry, vol. 59, no. 13, pp. 6957–6965, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Suda, I. Morita, T. Kuroda, and S.-I. Murota, “Participation of oxidative stress in the process of osteoclast differentiation,” Biochimica et Biophysica Acta—General Subjects, vol. 1157, no. 3, pp. 318–323, 1993. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Ozgocmen, H. Kaya, E. Fadillioglu, R. Aydogan, and Z. Yilmaz, “Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis,” Molecular and Cellular Biochemistry, vol. 295, no. 1-2, pp. 45–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Ozgocmen, H. Kaya, E. Fadillioglu, and Z. Yilmaz, “Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis,” Archives of Medical Research, vol. 38, no. 2, pp. 196–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Kamalakkannan and P. Stanely Mainzen Prince, “Effect of Aegle marmelos Correa. (Bael) fruit extract on tissue antioxidants in streptozotocin diabetic rats,” Indian Journal of Experimental Biology, vol. 41, no. 11, pp. 1285–1288, 2003. View at Google Scholar · View at Scopus
  77. P.-C. Chao, C.-C. Hsu, and M.-C. Yin, “Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice,” Nutrition and Metabolism, vol. 6, article 33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Stanely Mainzen Prince, N. Kamalakkannan, and V. P. Menon, “Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain,” Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 205–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Otto, M. Lübbert, and M. Stock, “Upstream and downstream targets of RUNX proteins,” Journal of Cellular Biochemistry, vol. 89, no. 1, pp. 9–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Häkkinen, M. Heinonen, S. Kärenlampi, H. Mykkänen, J. Ruuskanen, and R. Törrönen, “Screening of selected flavonoids and phenolic acids in 19 berries,” Food Research International, vol. 32, no. 5, pp. 345–353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Devareddy, S. Hooshmand, J. K. Collins, E. A. Lucas, S. C. Chai, and B. H. Arjmandi, “Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis,” Journal of Nutritional Biochemistry, vol. 19, no. 10, pp. 694–699, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Deyhim, K. Garica, E. Lopez et al., “Citrus juice modulates bone strength in male senescent rat model of osteoporosis,” Nutrition, vol. 22, no. 5, pp. 559–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. R. T. Franceschi, B. S. Iyer, and Y. Cui, “Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells,” Journal of Bone and Mineral Research, vol. 9, no. 6, pp. 843–854, 1994. View at Google Scholar · View at Scopus
  84. R. L. Prior, G. Cao, A. Martin et al., “Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity, and variety of Vaccinium species,” Journal of Agricultural and Food Chemistry, vol. 46, no. 7, pp. 2686–2693, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Arai, Y. Shibata, K. Pugdee, Y. Abiko, and Y. Ogata, “Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells,” IUBMB Life, vol. 59, no. 1, pp. 27–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. P. M. Jehle, D. R. Jehle, S. Mohan, and B. O. Böhm, “Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients,” Journal of Endocrinology, vol. 159, no. 2, pp. 297–306, 1998. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Collin-Osdoby, L. Rothe, S. Bekker, F. Anderson, Y. Huang, and P. Osdoby, “Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro,” Journal of Bone and Mineral Research, vol. 17, no. 10, pp. 1859–1871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Hayek, F. L. Culler, G. M. Beattie, A. D. Lopez, P. Cuevas, and A. Baird, “An in vivo model for study of the angiogenic effects of basic fibroblast growth factor,” Biochemical and Biophysical Research Communications, vol. 147, no. 2, pp. 876–880, 1987. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Montesano, J.-D. Vassalli, A. Baird, R. Guillemin, and L. Orci, “Basic fibroblast growth factor induces angiogenesis in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 19, pp. 7297–7301, 1986. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Zellin and A. Linde, “Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo,” Bone, vol. 26, no. 2, pp. 161–168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Debiais, M. Hott, A. M. Graulet, and P. J. Marie, “The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific,” Journal of Bone and Mineral Research, vol. 13, no. 4, pp. 645–654, 1998. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Fakhry, C. Ratisoontorn, C. Vedhachalam et al., “Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential,” Bone, vol. 36, no. 2, pp. 254–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. C. W. Karpen, R. G. Spanheimer, A. L. Randolph, and W. L. Lowe Jr., “Tissue-specific regulation of basic fibroblast growth factor mRNA levels by diabetes,” Diabetes, vol. 41, no. 2, pp. 222–226, 1992. View at Publisher · View at Google Scholar · View at Scopus
  94. K. P. Malabanan, P. Kanellakis, A. Bobik, and L. M. Khachigian, “Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury,” Circulation Research, vol. 103, no. 4, pp. 378–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. W.-T. Lai, V. Krishnappa, and D. G. Phinney, “Fibroblast growth factor 2 (FGF-2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering fgf receptor expression levels,” Stem Cells, vol. 29, no. 7, pp. 1102–1111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. Fei, L. Xiao, T. Doetschman, D. J. Coffin, and M. M. Hurley, “Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway,” Journal of Biological Chemistry, vol. 286, no. 47, pp. 40575–40583, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. T. F. Day, X. Guo, L. Garrett-Beal, and Y. Yang, “Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis,” Developmental Cell, vol. 8, no. 5, pp. 739–750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. W. H. Chou, Comprising Aliquot of the Herb Herba Epimedii and Aliquot of Three Supplemental Herbs Selected from Fructus Rosae Laevigatae, Fructus Rubi, Fructus Psoralea, Radix Morindae Officinalis, Fructus Schisandrac Chinensis, and Others, Google Patents, 2007.
  99. M. Spilmont, L. Léotoing, M.-J. Davicco et al., “Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status,” The Journal of Nutritional Biochemistry, vol. 24, no. 11, pp. 1840–1848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Zhang, J. Su, J. Yu et al., “An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation,” Journal of Bone and Mineral Research, vol. 26, no. 3, pp. 604–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Komori, H. Yagi, S. Nomura et al., “Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts,” Cell, vol. 89, no. 5, pp. 755–764, 1997. View at Publisher · View at Google Scholar · View at Scopus
  102. E. P. Lansky and R. A. Newman, “Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer,” Journal of Ethnopharmacology, vol. 109, no. 2, pp. 177–206, 2007. View at Publisher · View at Google Scholar · View at Scopus